Kiyoyuki Ishikawa, CPA

Chief Financial Officer

Professional Overview
Kiyoyuki Ishikawa is an accomplished finance executive with over 40 years of experience in the pharmaceutical industry. As the Chief Financial Officer of Kowa Pharmaceuticals America, Inc., he oversees the company's financial operations, strategic planning, and corporate governance, contributing to its ongoing success and growth.

Experience Summary

Current Role
As the Chief Financial Officer of Kowa Pharmaceuticals America, Inc., Kiyoyuki Ishikawa is responsible for managing the company's financial strategies, budgeting, and reporting. He has played a pivotal role in maintaining the company's financial stability and driving its expansion in the United States market. Under his leadership, Kowa Pharmaceuticals America has consistently achieved strong financial performance and operational efficiency.

Career Progression
Kiyoyuki Ishikawa's career journey spans various leadership roles within the Kowa group of companies. Prior to his current position, he served as an Executive Officer at Kowa Company Ltd., where he contributed to the company's global financial operations. He also held the roles of President, Treasurer, and General Manager at Kowa American Corporation, demonstrating his versatility and ability to thrive in diverse organizational settings.

Academic Background
Kiyoyuki Ishikawa holds a Bachelor's degree in Accounting from the University of Tokyo. He is a Certified Public Accountant (CPA), bringing a strong technical expertise and financial acumen to his work.

Areas of Expertise

• Financial management and strategic planning

• Corporate governance and compliance

• International business operations

• Mergers, acquisitions, and integration

• Risk management and internal controls

Professional Impact
Throughout his career, Kiyoyuki Ishikawa has made significant contributions to the growth and success of the Kowa group of companies. His leadership in financial strategy and operational optimization has been instrumental in driving the company's expansion and maintaining its competitive edge in the pharmaceutical market. Kiyoyuki's deep industry knowledge and strategic vision have been invaluable in navigating complex financial and operational challenges.

Conclusion
Kiyoyuki Ishikawa's extensive experience and proven track record as a finance executive make him a valuable asset to Kowa Pharmaceuticals America. His strong technical skills, strategic mindset, and commitment to organizational excellence continue to drive the company's financial performance and support its long-term growth objectives.